deltatrials
Completed PHASE2 NCT01716858

An Open Study of Sulforaphane-rich Broccoli Sprout Extract in Patients With Schizophrenia

Sulforaphane-rich Broccoli Sprout Extract for Schizophrenia

Sponsor: Chiba University

Conditions Schizophrenia
Interventions Sulforaphane-rich Broccoli Sprout Extract
Updated 5 times since 2017 Last updated: Jul 28, 2015 Started: Oct 31, 2012 Primary completion: Sep 30, 2013 Completion: Mar 31, 2014

This PHASE2 trial investigates Schizophrenia and is currently completed. Chiba University leads this study, which shows 5 recorded versions since 2012 — indicating limited longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE2

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE2

    First recorded

Oct 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Chiba University
Data source: Chiba University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Chiba, Japan